Active Biotech AB (BTPC)'s Project ANYARA Will Be Presented at the European Cancer Congress 2013
9/12/2013 9:37:45 AM
Lund (Sweden), September 12, 2013. Active Biotech (NASDAQ OMX NORDIC: ACTI)
today announced that a biomarker trend analysis of overall survival (OS) and
Progression Free Survival (PFS) from the ANYARA Phase II/III study in renal cell
cancer will be presented at the scientific conference "European Cancer Congress
2013" (ECCO-ESMO-ESTRO) held in Amsterdam, the Netherlands, September 27 -
Help employers find you! Check out all the jobs and post your resume.